XML 35 R20.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Quarterly Results | 12 Months Ended
--- | ---
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract] |
Quarterly Results | 12) QUARTERLY RESULTS (unaudited) The following tables summarize the quarterly financial data for the two years ended December 31, 2015 and 2014:
2015 |  | First Quarter |  |  | Second Quarter |  |  | Third Quarter |  |  | Fourth Quarter |  |  | Total |
|  | (amounts in thousands, except per share amounts) |
Net revenues |  | $ | 2,225,353 |  |  | $ | 2,275,204 |  |  | $ | 2,227,655 |  |  | $ | 2,315,239 |  |  | $ | 9,043,451 |
Net income |  | $ | 194,323 |  |  | $ | 201,404 |  |  | $ | 163,654 |  |  | $ | 191,317 |  |  | $ | 750,698 |
Less: Net income attributable to noncontrolling interests |  | $ | 20,024 |  |  | $ | 19,211 |  |  | $ | 13,367 |  |  | $ | 17,568 |  |  | $ | 70,170 |
Net income attributable to UHS |  | $ | 174,299 |  |  | $ | 182,193 |  |  | $ | 150,287 |  |  | $ | 173,749 |  |  | $ | 680,528 |
Earnings per share attributable to UHS-Basic: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total basic earnings per share |  | $ | 1.76 |  |  | $ | 1.84 |  |  | $ | 1.52 |  |  | $ | 1.76 |  |  | $ | 6.89 |
Earnings per share attributable to UHS-Diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total diluted earnings per share |  | $ | 1.73 |  |  | $ | 1.80 |  |  | $ | 1.48 |  |  | $ | 1.74 |  |  | $ | 6.76 |
The 2015 quarterly financial data presented above includes the following: First Quarter:
| · | an unfavorable $8.3 million pre-tax impact ($5.3 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;
Second Quarter:
| · | an unfavorable $6.9 million pre-tax impact ($4.4 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications.
Third Quarter:
| · | an unfavorable $8.0 million pre-tax impact ($5.0 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;
Fourth Quarter:
| · | a favorable $4.9 million pre-tax impact ($3.1 million, or $.03 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;
2014 |  | First Quarter |  |  | Second Quarter |  |  | Third Quarter |  |  | Fourth Quarter |  |  | Total |
|  | (amounts in thousands, except per share amounts) |
Net revenues |  | $ | 1,938,314 |  |  | $ | 2,051,766 |  |  | $ | 2,038,717 |  |  | $ | 2,176,291 |  |  | $ | 8,205,088 |
Net income |  | $ | 151,852 |  |  | $ | 166,614 |  |  | $ | 96,038 |  |  | $ | 190,492 |  |  | $ | 604,996 |
Less: Net income attributable to noncontrolling interests |  | $ | 13,774 |  |  | $ | 14,943 |  |  | $ | 13,241 |  |  | $ | 17,695 |  |  | $ | 59,653 |
Net income attributable to UHS |  | $ | 138,078 |  |  | $ | 151,671 |  |  | $ | 82,797 |  |  | $ | 172,797 |  |  | $ | 545,343 |
Earnings per share attributable to UHS-Basic: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total basic earnings per share |  | $ | 1.40 |  |  | $ | 1.53 |  |  | $ | 0.84 |  |  | $ | 1.75 |  |  | $ | 5.52 |
Earnings per share attributable to UHS-Diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total diluted earnings per share |  | $ | 1.38 |  |  | $ | 1.51 |  |  | $ | 0.82 |  |  | $ | 1.71 |  |  | $ | 5.42 |
The 2014 quarterly financial data presented above includes the following: First Quarter:
| · | an unfavorable $8.9 million pre-tax impact ($4.9 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;
| · | a favorable $10.1 million pre-tax impact ($6.3 million, or $0.07 per diluted share, net of taxes) resulting from the gain realized on the sale of a non-operating investment.
Second Quarter:
| · | an unfavorable $7.1 million pre-tax impact ($3.9 million, or $.04 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications.
Third Quarter:
| · | an unfavorable $7.9 million pre-tax impact ($4.5 million, or $.04 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;
| · | an unfavorable $36.2 million pre-tax impact ($22.7 million, or $0.23 per diluted share, net of taxes) recorded in connection with the costs related to extinguishment of debt resulting primarily from the early redemption of our previously outstanding $250 million, 7.00% senior unsecured notes that were scheduled to mature in 2018 and the repayment of $550 million of borrowings pursuant to the terms of our previously outstanding Term Loan B facility which was scheduled to mature in 2016;
| · | an unfavorable $44.0 million pre-tax impact ($27.6 million, or $0.27 per diluted share, net of taxes) incurred in connection with the previously disclosed $65 million settlement of the Garden City matter. This matter was a shareholder class action lawsuit filed in 2009 against PSI and certain of its former officers alleging their violations of federal securities laws and we assumed the defense and liability of this matter as a result of our acquisition of PSI in 2010. This charge is net of approximately $17 million of commercial insurance recoveries that we were entitled to and a previously recorded estimated reserve;
Fourth Quarter:
| · | a favorable $13.8 million pre-tax impact ($8.6 million, or $.08 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;
| · | A favorable $19.7 million pre-tax impact reduction ($11.7 million, or $.12 per diluted share, net of taxes) to our professional and general liability self-insurance reserves relating to years prior to 2014, as discussed in Self-Insured/Other Insurance Risks.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e765-108305 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a)-(j) -URI http://asc.fasb.org/extlink&oid=51825399&loc=d3e1280-108306 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e725-108305 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section G -Subsection 1 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K (SK) -Number 229 -Section 302 -Paragraph a + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration